ClinicalTrials.gg
Active, not recruitingNCT06678438Updated Sep 21, 2026

Brachial Plexus Nerve Block Versus Haematoma Block for Closed Reduction of Distal Radius Fracture in Adults - The BLOCK Trial. A Multicentre Randomised Controlled Trial.

A Phase 4 interventional study of Ultrasound-guided brachial plexus block and Haematoma Block in Distal Radius Fractures, Fracture Dislocation and Fracture Dislocation of Upper Limb Joint, sponsored by Nordsjaellands Hospital. Active, not recruiting at 1 site in Denmark. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-21.

Sponsored by Nordsjaellands Hospital · Phase 4, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 4
Study type
Interventional
Enrollment
1,716
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 11 studies in Wrist Fractures with a site in Denmark — 2 open to participants now, 4 under way, none of them phase 3. Wrist Fractures · Denmark.

Planned enrollment
Largest of 10
1,716 · median 125
Started
2024
with 1 other
Phase 4
Only one
of the 11
Registered
9th of 11
by date
Lead sponsor
4 of 11
Nordsjaellands Hospital

Among the 11 studies in Wrist Fractures with a site in Denmark, this one has the largest planned enrollment of the 10 interventional ones that give a count, is one of 2 that started in 2024, is the only one in phase 4, and was the 9th registered.

Wrist Fractures

331 studies on the registry are indexed under Wrist Fractures; 71 are open to participants now.

Browse Wrist Fractures studies →

Open to participants now

2 of the 11 studies in Wrist Fractures with a site in Denmark are open now. Recruiting first, the newest first:

All 2 open studies →

A study can be open while its sites in Denmark have not opened yet or have stopped. Only those recruiting at a site in Denmark →

Who these studies take

Of the 41 Wrist Fractures studies recruiting now, 20 (49%) set no upper age limit and 13 (32%) stop at 75 or younger; 7 take children under 18; 6 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 11 studies in Wrist Fractures with a site in Denmark, or all of them as a file.
02

Study summary

The aim of the project is to evaluate the beneficial and harmful effects of an ultrasound-guided brachial plexus nerve block for patients with a distal radius (wrist) fracture in the need of realignment of fractured bone endings without cutting the skin (closed reduction), in comparison to a haematoma block, which is standard care in Denmark.

Every participant will receive one of the following types of anaesthesia for the realignment of the wrist fracture:

  1. A nerve block of the arm (plexus brachialis block)
  2. A haematoma block, which is the current standard anaesthesia in the emergency departments.
03

Conditions studied

  • Distal Radius Fractures
  • Fracture Dislocation
  • Fracture Dislocation of Upper Limb Joint
  • Colles' Fracture
  • Closed Reduction of Fracture and Application of Plaster Cast

Keywords

  • Lidocaine
  • Local anaesthesia
  • Regional anaesthesia
  • Peripheral nerve block
  • Brachial plexus block
  • Lateral infraclavicular block
  • Axillary plexus block
  • Distal radius fracture
  • Colles' fracture
  • Wrist fracture
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults (age ≥ 18 years) with a distal radius fracture in need of closed reduction

Exclusion criteria

Exclusion Criteria:

  • Patients who would never qualify for surgery according to local guidelines
  • Lack of
  • No Danish Central Person Register (CPR) number
  • Allergies to the trial medication
  • Distal radius fracture initially deemed to require surgery regardless of the outcome of the closed reduction
  • Open fractures (fracture-related wound requiring sutures)
  • Other fractures on the same extremity ((NOT including distal ulna fracture(s))
  • Bilateral distal radius fractures both requiring closed reduction
  • Concomitant medical or surgical condition taking priority over the closed reduction of the distal radius fracture.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
1,716 participants (estimated)

Study arms

  • Experimental
    Intervention group

    Ultrasound-guided brachial plexus nerve block. A total of 30 ml of lidocaine (10 mg/ml) with adrenaline (5 ug/ml) will be administered in multiple injections.

    Procedure: Ultrasound-guided brachial plexus block

  • Active comparator
    Control group

    Haematoma block with local anaesthetics i.e. lidocaine with adrenaline

    Procedure: Haematoma Block

Interventions

  • ProcedureUltrasound-guided brachial plexus block

    The block will be performed as either a lateral infraclavicular brachial plexus block or an axillary brachial plexus block

  • ProcedureHaematoma Block

    Participants will receive no peripheral nerve block and receive a haematoma block, with or without supplemental sedation and/or systemic analgesia for the closed reduction according to local guidelines and clinical practices

06

What researchers measure

Primary outcomes

  1. Cumulative proportion of patients with distal radius fracture surgery

    Time frame: 90 days after closed reduction

Secondary outcomes

  1. Composite outcome of treatment related complications

    loco-regional neurological complications from affected arm, local anaesthetic systemic toxicity, soft tissue injuries (including skin injuries) related to the closed reduction procedure, infection at the site of needle puncture, vessel puncture requiring subsequent treatment (including compression), pneumothorax, allergic reaction, new bone or joint injury (e.g. dislocation or fracture) after the closed reduction and/or pulmonary embolism

    Time frame: 90 days after closed reduction

  2. Patient Rated Wrist Evaluation (PRWE)

    The PRWE is a patient-reported outcome and the PRWE-score is calculated from the Danish-validated translation of the PRWE questionnaire

    Time frame: 90 days after closed reduction

  3. Maximum pain score in the affected wrist during closed reduction(s)

    The pain outcomes are patient-reported as a Numerical Rating Scale (NRS) score on a scale from 0=no pain to 10=worst pain imaginable. If the patient has the closed reduction performed more than one time, the patient will be asked to report the worst pain experienced during all the attempts of a closed reduction.

    Time frame: 0-12 hours after the closed reduction

  4. Proportion of patients with unacceptable radiographic fracture position immediately after closed reduction

    The radiographic fracture position is evaluated according to the American Academy of Orthopaedic Surgerons (AAOS) guidelines. The fracture position is unacceptable if the fracture has a radial shortening \> 3 mm, \> 10 degrees dorsal tilt of the articular surface of radius from a perpendicular line on the longitudianal axis of radius or intra-articular displacement or step-off \> 2 mm.

    Time frame: 0 -24 hours after closed reduction

Other outcomes

  1. Pain at rest in the affected wrist immediately, 90 days, and 12 months after closed reduction

    The pain outcomes are patient-reported as a Numerical Rating Scale (NRS) score on a scale from 0=no pain to 10=worst pain imaginable.

    Time frame: 0-12 hours, 90 days and 12 months after closed reduction

  2. Maximum pain in the affected wrist within the first 24 hours after closed reduction

    The pain outcomes are patient-reported as an NRS score on a scale from 0=no pain to 10=worst pain imaginable.

    Time frame: 24-36 hours after the closed reduction.

  3. Proportion of patients with complex regional pain syndrome (CRPS)

    CRPS is defined according to the Budapest Criteria

    Time frame: 90 days and 12 months after closed reduction

  4. Disabilities of the Arm, Shoulder, and Hand (DASH) score

    DASH-score is calculated from the Danish-validated translation of the DASH questionnaire

    Time frame: 90 days and 12 months after closed reduction

  5. Patient Rated Wrist Evaluation (PRWE)

    PRWE-score is calculated from the Danish-validated translation of the PRWE questionnaire

    Time frame: 12 months after closed reduction

  6. Quality of life (EQ-5D-5L) score

    The Danish translation of the EQ-5D-5L questionnaire is used and the EQ-5D-5L-score is calculated based on the Danish EQ-5D-5L value set

    Time frame: 90 days and 12 months after closed reduction

  7. Number of attempts used for closed reduction

    Time frame: Immediately after closed reduction

  8. Difficulty of closed reduction of the fracture

    The doctor reported ease on a numeric rating scale from 0-10; 0=very easy, 10=very difficult)

    Time frame: Immediately after closed reduction

  9. Discomfort related to the anaesthetic procedure

    The discomfort is a patient-reported outcome on a numeric rating scale from 0-10; 0=no discomfort, 10=very uncomfortable

    Time frame: 0-12 hours after closed reduction

  10. Overall satisfaction with the treatment 0 to 24 hours after initiation of the anaesthesia

    The overall satisfaction is a patient-reported outcome on a numeric rating scale from 0-10; 0=very unsatisfied, 10=very satisfied. When evaluating the treatment, the patient is specifically asked to include all elements of the treatment including: the anaesthetic (procedure and following effects), the experience during the closed reduction and the pain and general sensation in the arm/wrist in the first 24 hours after the treatment commencement.

    Time frame: 24 hours after closed reduction

  11. Proportion of patients with unacceptable radiographic position at first follow-up in the orthopaedic out-patient clinic (typically 10-14 days post-reduction)

    The radiographic fracture position is evaluated according to the American Academy of Orthopaedic Surgerons (AAOS) guidelines. The fracture position is unacceptable if the fracture has a radial shortening \> 3 mm, \> 10 degrees dorsal tilt of the articular surface of radius from a perpendicular line on the longitudianal axis of radius or intra-articular displacement or step-off \> 2 mm.

    Time frame: 10-14 days after closed reduction

  12. Proportion of individual complications in the composite secondary outcome

    Time frame: 90 days after closed reduction

  13. Proportion of patients having one or more serious adverse events (SAEs), including events related to loss of hand function

    A SAE is defined as an adverse event that leads to the following incidents: * Death * Life threatening injury or disease * Severe or permanent disability * Admission to the hospital or prolongation of hospitalisation Surgical reduction of the distal radius fracture, including relevant admission to hospital, will not be catagorised as a SAE.

    Time frame: Within 90 days after closed reduction

  14. Proportion of patients having one or more adverse events (AEs)

    An AE is defined as any harmful and unintended event, sign, or symptom, that appear during the trial period, regardless of whether this AE is considered related to the treatment or not.

    Time frame: Within 24 hours after closed reduction

07

Study locations

1 site
08

References and documents

Publications

  • Dupont Harwood C, Jellestad AL, Bahuet AR, Knudsen RL, Andersen LC, Mathiesen O, Asko Andersen J, Jakobsen JC, Rothe C, Jorgensen CC, Viberg B, Brorson S, Brabrand M, Gundtoft PH, Terndrup M, Lange KHW, Lundstrom LH, Norskov AK. Brachial plexus nerve block versus haematoma block for closed reduction of distal radius fracture in adults: The BLOCK Trial - a protocol for a multicentre randomised controlled trial. BMJ Open. 2025 Jul 8;15(7):e099954. doi: 10.1136/bmjopen-2025-099954. PubMed 40633950 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Dec 2024 (actual). Primary completion is estimated for Nov 2026, 23 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 6, 2024
First posted
Nov 7, 2024
StartActual
Dec 10, 2024
Primary completionEst.
Nov 24, 2026
CompletionEst.
Aug 24, 2027
Last update
Sep 21, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 21, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06678438
Lead sponsor
Nordsjaellands Hospital
Responsible party
Sponsor
First posted
Nov 7, 2024
Start date
Dec 10, 2024
Primary completion
Nov 24, 2026 (estimated)
Completion
Aug 24, 2027 (estimated)
Last update
Sep 21, 2026

Study contacts

Cecilie D Harwood, MD, PhD-fellow
principal investigator · Copenhagen University Hospital - North Zealand
Anne-Sofie Jellestad, MD, PhD-fellow
principal investigator · Copenhagen University Hospital - North Zealand

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion